CJC-1295 With DAC 10mg Research Vial — Coming Soon to Peptify UK
CJC-1295 With DAC 10mg. CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analogue researched for its sustained elevation of growth hormone levels due to its extended half-life. Higher dosage vial. For research use only.
This research peptide is studied in published growth-hormone-axis and body-composition research literature. CJC-1295 With DAC 10mg is supplied strictly as a lyophilised powder for in-vitro and preclinical research applications. Not approved by the MHRA for human therapeutic use; not for human consumption under any circumstances.
This 10mg vial is a mid-range research format sized to balance per-vial cost against reconstitution shelf-life for typical multi-week preclinical protocols.
What ships with the CJC-1295 With DAC 10mg vial
- Lyophilised research peptide vial — CJC-1295 With DAC 10mg
- Janoshik Analytical Certificate of Analysis specific to the production lot (independent Czech laboratory, not in-house QC)
- HPLC purity report — 99%+ purity standard before any vial is released
- Mass-spectrometry identity confirmation on the same COA
- UK Royal Mail Tracked dispatch from London — same-day if ordered before 1pm
Why CJC-1295 With DAC 10mg is currently coming-soon, not in-stock
Every Peptify SKU is held back from sale until the Janoshik Analytical COA arrives for the specific production lot. This is a deliberate stock-control policy — no batch ships before its certificate is in our hands, no exceptions. The CJC-1295 With DAC 10mg batch is in the Janoshik test queue; this product page will flip from "Coming Soon" to "Add to basket" the moment the lot-specific COA lands.
Background literature on this compound is collected on the Peptify CJC-1295 With DAC research hub, which catalogues published preclinical findings, mechanism-of-action notes, and reference half-life data — all sourced and citation-anchored.
Stock alert sign-up
Enter your email on this page to be notified when CJC-1295 With DAC 10mg is released. Stock alerts go out the same hour the COA is uploaded — no marketing emails, no list-rental, just the one stock-back notification.
Supplier & compliance
PEPTIFY LIMITED is registered at Companies House under company number #17021295, incorporated 9 February 2026. Registered office: 6th Floor, 37 Lombard Street, London, EC3V 9BQ. UK IPO trademark applications under prosecution: UK00004350730 (word mark) and UK00004378672 (combined mark). All Peptify research peptides are sold for laboratory and preclinical research use only.
For research use only. Not for human consumption.